Company: EDSA
Filing Date: 2025-03-04
Form Type: S-3
Source: 0001171843-25-001239
Chunk: 15

Company: Edesa Biotech, Inc.
Filing Date: 2025-03-04
Form: S-3
Chunk 15
---
 earn on any resale of the Shares
or the Conversion Shares may be underwriting discounts and commissions under the Securities Act. Selling Shareholders who are “underwriters”
within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act.

To the extent required, the Shares or the Conversion
Shares to be sold, the names of the Selling Shareholders, the respective purchase prices and public offering prices, the names of any
agents, dealer or underwriter, any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying
prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.

In order to comply with the securities laws of some
states, if applicable, the Shares or the Conversion Shares may be sold in these jurisdictions only through registered or licensed brokers
or dealers. In addition, in some states the Shares or the Conversion Shares may not be sold unless it has been registered or qualified
for sale or an exemption from registration or qualification requirements is available and is complied with.

We have advised the Selling Shareholders that the anti-manipulation
rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the Selling Shareholders
and their affiliates. In addition, we will make copies of this prospectus (as it may be supplemented or amended from time to time) available
to the Selling Shareholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The Selling Shareholders
may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including
liabilities arising under the Securities Act.

We have agreed to indemnify the Selling Shareholders
against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares
offered by this prospectus.

We have agreed with the Selling Shareholders to keep
the registration statement of which this prospectus constitutes a part effective until such time as the Shares or the Conversion Shares
offered by the Selling Shareholders have been effectively registered under the Securities Act and disposed of in accordance with such
registration statement, the Shares or the Conversion Shares offered by the Selling Shareholders have been disposed of pursuant to Rule
144 under the Securities Act or the shares offered by the Selling Shareholders may be resold pursuant to Rule 144 without restriction
or limitation (including without the requirement to be in compliance with